Aurobindo's US Respiratory Filing Could Rival Teva's Qvar

As Indian Company Enters Fray For COVID-19 Vaccine

 
• By Vibha Ravi
  
Start line
Aurobindo Pharma: Late Starter In The COVID-19 Vaccine Race • Source: Shutterstock

More from Earnings

More from Business